FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - February 11, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altaire Pharmaceuticals, Inc.

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on February 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Altaire Pharmaceuticals, Inc.
Inspection Date: February 11, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 0c20c70c-b178-4306-8b90-55ba5c3ee376